Advertisement

Index by author

May 01, 1984; Volume 25,Issue 3

A

  1. Aguayo, L G

    1. Interactions of phencyclidine with crayfish muscle membranes. Sensitivity to calcium channel antagonists and other drugs.
      E E El-Fakahany, A T Eldefrawi, D L Murphy, L G Aguayo, D J Triggle, E X Albuquerque and M E Eldefrawi
      Molecular Pharmacology May 1984, 25 (3) 369-378;

  2. Albuquerque, E X

    1. Interactions of phencyclidine with crayfish muscle membranes. Sensitivity to calcium channel antagonists and other drugs.
      E E El-Fakahany, A T Eldefrawi, D L Murphy, L G Aguayo, D J Triggle, E X Albuquerque and M E Eldefrawi
      Molecular Pharmacology May 1984, 25 (3) 369-378;
    2. Interactions of gephyrotoxin with the acetylcholine receptor-ionic channel complex. I. Blockade of the ionic channel.
      C Souccar, W A Varanda, J W Daly and E X Albuquerque
      Molecular Pharmacology May 1984, 25 (3) 384-394;
    3. Interactions of gephyrotoxin with the acetylcholine receptor-ionic channel complex. II. Enhancement of desensitization.
      C Souccar, W A Varanda, R S Aronstam, J W Daly and E X Albuquerque
      Molecular Pharmacology May 1984, 25 (3) 395-400;

  3. Aronstam, R S

    1. Interactions of gephyrotoxin with the acetylcholine receptor-ionic channel complex. II. Enhancement of desensitization.
      C Souccar, W A Varanda, R S Aronstam, J W Daly and E X Albuquerque
      Molecular Pharmacology May 1984, 25 (3) 395-400;

B

  1. Bamberger, M J

    1. Mechanism of phencyclidine binding to the acetylcholine receptor from Torpedo electroplaque.
      R E Oswald, M J Bamberger and J T McLaughlin
      Molecular Pharmacology May 1984, 25 (3) 360-368;

  2. Bartel, R L

    1. Effects of adenosine dialdehyde on S-adenosylhomocysteine hydrolase and S-adenosylmethionine-dependent transmethylations in mouse L929 cells.
      R L Bartel and R T Borchardt
      Molecular Pharmacology May 1984, 25 (3) 418-424;

  3. Bartolucci, S

    1. Kinetic interaction of 5-AZA-2'-deoxycytidine-5'-monophosphate and its 5'-triphosphate with deoxycytidylate deaminase.
      R L Momparler, M Rossi, J Bouchard, C Vaccaro, L F Momparler and S Bartolucci
      Molecular Pharmacology May 1984, 25 (3) 436-440;

  4. Baxter, D M

    1. Physical properties and lipid composition of brain membranes from ethanol tolerant-dependent mice.
      R A Harris, D M Baxter, M A Mitchell and R J Hitzemann
      Molecular Pharmacology May 1984, 25 (3) 401-409;
    2. Gangliosides enhance the membrane actions of ethanol and pentobarbital.
      R A Harris, G I Groh, D M Baxter and R J Hitzemann
      Molecular Pharmacology May 1984, 25 (3) 410-417;

  5. Billings, R E

    1. Decreased hepatic 5, 10-methylenetetrahydrofolate reductase activity in mice after chronic phenytoin treatment.
      R E Billings
      Molecular Pharmacology May 1984, 25 (3) 459-466;

  6. Blisard, K S

    1. Substrate specificity of the monooxygenase activity of hemoglobin.
      D W Starke, K S Blisard and J J Mieyal
      Molecular Pharmacology May 1984, 25 (3) 467-475;

  7. Borchardt, R T

    1. Effects of adenosine dialdehyde on S-adenosylhomocysteine hydrolase and S-adenosylmethionine-dependent transmethylations in mouse L929 cells.
      R L Bartel and R T Borchardt
      Molecular Pharmacology May 1984, 25 (3) 418-424;

  8. Bouchard, J

    1. Kinetic interaction of 5-AZA-2'-deoxycytidine-5'-monophosphate and its 5'-triphosphate with deoxycytidylate deaminase.
      R L Momparler, M Rossi, J Bouchard, C Vaccaro, L F Momparler and S Bartolucci
      Molecular Pharmacology May 1984, 25 (3) 436-440;

C

  1. Chen, M S

    1. Molecular basis of the antineoplastic activity of 3'-amino-3'-deoxythymidine.
      M S Chen, K L Woods and W H Prusoff
      Molecular Pharmacology May 1984, 25 (3) 441-445;

  2. Chuang, D M

    1. Modulation by calcium of gamma-aminobutyric acid (GABA) binding to GABAA and GABAB recognition sites in rat brain. Involvement of different mechanisms.
      M D Majewska and D M Chuang
      Molecular Pharmacology May 1984, 25 (3) 352-359;

  3. Conway, J G

    1. Glucuronidation of 7-hydroxycoumarin in periportal and pericentral regions of the liver lobule.
      J G Conway, F C Kauffman, T Tsukada and R G Thurman
      Molecular Pharmacology May 1984, 25 (3) 487-493;

  4. Coon, M J

    1. Purification of liver microsomal cytochrome P-450 isozymes 3a and 6 from imidazole-treated rabbits. Evidence for the identity of isozyme 3a with the form obtained by ethanol treatment.
      D R Koop and M J Coon
      Molecular Pharmacology May 1984, 25 (3) 494-501;

D

  1. Daly, J W

    1. Interactions of gephyrotoxin with the acetylcholine receptor-ionic channel complex. I. Blockade of the ionic channel.
      C Souccar, W A Varanda, J W Daly and E X Albuquerque
      Molecular Pharmacology May 1984, 25 (3) 384-394;
    2. Interactions of gephyrotoxin with the acetylcholine receptor-ionic channel complex. II. Enhancement of desensitization.
      C Souccar, W A Varanda, R S Aronstam, J W Daly and E X Albuquerque
      Molecular Pharmacology May 1984, 25 (3) 395-400;

  2. Dibartolomeis, M J

    1. The interrelationship of polycyclic hydrocarbon metabolism and steroidogenesis in primary cultures of bovine adrenal cortical cells.
      M J Dibartolomeis and C R Jefcoate
      Molecular Pharmacology May 1984, 25 (3) 476-486;

E

  1. El-Fakahany, E E

    1. Interactions of phencyclidine with crayfish muscle membranes. Sensitivity to calcium channel antagonists and other drugs.
      E E El-Fakahany, A T Eldefrawi, D L Murphy, L G Aguayo, D J Triggle, E X Albuquerque and M E Eldefrawi
      Molecular Pharmacology May 1984, 25 (3) 369-378;

  2. Eldefrawi, A T

    1. Interactions of phencyclidine with crayfish muscle membranes. Sensitivity to calcium channel antagonists and other drugs.
      E E El-Fakahany, A T Eldefrawi, D L Murphy, L G Aguayo, D J Triggle, E X Albuquerque and M E Eldefrawi
      Molecular Pharmacology May 1984, 25 (3) 369-378;

  3. Eldefrawi, M E

    1. Interactions of phencyclidine with crayfish muscle membranes. Sensitivity to calcium channel antagonists and other drugs.
      E E El-Fakahany, A T Eldefrawi, D L Murphy, L G Aguayo, D J Triggle, E X Albuquerque and M E Eldefrawi
      Molecular Pharmacology May 1984, 25 (3) 369-378;

F

  1. Fischer, P H

    1. Antagonism of feedback inhibition. Stimulation of the phosphorylation of thymidine and 5-iodo-2'-deoxyuridine by 5-iodo-5'-amino-2',5'-dideoxyuridine.
      P H Fischer and A W Phillips
      Molecular Pharmacology May 1984, 25 (3) 446-451;

G

  1. Gargiulo, P

    1. Human placenta aldose reductase. Forms sensitive and insensitive to inhibition by alrestatin.
      M E Maragoudakis, J Wasvary, H Hankin and P Gargiulo
      Molecular Pharmacology May 1984, 25 (3) 425-430;

  2. Goldstein, A

    1. Site-directed alkylation of multiple opioid receptors. I. Binding selectivity.
      I F James and A Goldstein
      Molecular Pharmacology May 1984, 25 (3) 337-342;
    2. Site-directed alkylation of multiple opioid receptors. II. Pharmacological selectivity.
      A Goldstein and I F James
      Molecular Pharmacology May 1984, 25 (3) 343-348;

  3. Gresh, N

    1. A theoretical study of the nonintercalative binding of berenil and stilbamidine to double-stranded (dA-dT)n oligomers.
      N Gresh and B Pullman
      Molecular Pharmacology May 1984, 25 (3) 452-458;

  4. Groh, G I

    1. Gangliosides enhance the membrane actions of ethanol and pentobarbital.
      R A Harris, G I Groh, D M Baxter and R J Hitzemann
      Molecular Pharmacology May 1984, 25 (3) 410-417;

H

  1. Hankin, H

    1. Human placenta aldose reductase. Forms sensitive and insensitive to inhibition by alrestatin.
      M E Maragoudakis, J Wasvary, H Hankin and P Gargiulo
      Molecular Pharmacology May 1984, 25 (3) 425-430;

  2. Harris, R A

    1. Physical properties and lipid composition of brain membranes from ethanol tolerant-dependent mice.
      R A Harris, D M Baxter, M A Mitchell and R J Hitzemann
      Molecular Pharmacology May 1984, 25 (3) 401-409;
    2. Gangliosides enhance the membrane actions of ethanol and pentobarbital.
      R A Harris, G I Groh, D M Baxter and R J Hitzemann
      Molecular Pharmacology May 1984, 25 (3) 410-417;

  3. Hitzemann, R J

    1. Physical properties and lipid composition of brain membranes from ethanol tolerant-dependent mice.
      R A Harris, D M Baxter, M A Mitchell and R J Hitzemann
      Molecular Pharmacology May 1984, 25 (3) 401-409;
    2. Gangliosides enhance the membrane actions of ethanol and pentobarbital.
      R A Harris, G I Groh, D M Baxter and R J Hitzemann
      Molecular Pharmacology May 1984, 25 (3) 410-417;

J

  1. James, I F

    1. Site-directed alkylation of multiple opioid receptors. I. Binding selectivity.
      I F James and A Goldstein
      Molecular Pharmacology May 1984, 25 (3) 337-342;
    2. Site-directed alkylation of multiple opioid receptors. II. Pharmacological selectivity.
      A Goldstein and I F James
      Molecular Pharmacology May 1984, 25 (3) 343-348;

  2. Jefcoate, C R

    1. The interrelationship of polycyclic hydrocarbon metabolism and steroidogenesis in primary cultures of bovine adrenal cortical cells.
      M J Dibartolomeis and C R Jefcoate
      Molecular Pharmacology May 1984, 25 (3) 476-486;

  3. Jekunen, A

    1. 5-Methyl-2'-deoxycytidine. Metabolism and effects on cell lethality studied with human leukemic cells in vitro.
      A Jekunen and J A Vilpo
      Molecular Pharmacology May 1984, 25 (3) 431-435;

K

  1. Kauffman, F C

    1. Glucuronidation of 7-hydroxycoumarin in periportal and pericentral regions of the liver lobule.
      J G Conway, F C Kauffman, T Tsukada and R G Thurman
      Molecular Pharmacology May 1984, 25 (3) 487-493;

  2. Koop, D R

    1. Purification of liver microsomal cytochrome P-450 isozymes 3a and 6 from imidazole-treated rabbits. Evidence for the identity of isozyme 3a with the form obtained by ethanol treatment.
      D R Koop and M J Coon
      Molecular Pharmacology May 1984, 25 (3) 494-501;

M

  1. Majewska, M D

    1. Modulation by calcium of gamma-aminobutyric acid (GABA) binding to GABAA and GABAB recognition sites in rat brain. Involvement of different mechanisms.
      M D Majewska and D M Chuang
      Molecular Pharmacology May 1984, 25 (3) 352-359;

  2. Maragoudakis, M E

    1. Human placenta aldose reductase. Forms sensitive and insensitive to inhibition by alrestatin.
      M E Maragoudakis, J Wasvary, H Hankin and P Gargiulo
      Molecular Pharmacology May 1984, 25 (3) 425-430;

  3. McLaughlin, J T

    1. Mechanism of phencyclidine binding to the acetylcholine receptor from Torpedo electroplaque.
      R E Oswald, M J Bamberger and J T McLaughlin
      Molecular Pharmacology May 1984, 25 (3) 360-368;

  4. Mieyal, J J

    1. Substrate specificity of the monooxygenase activity of hemoglobin.
      D W Starke, K S Blisard and J J Mieyal
      Molecular Pharmacology May 1984, 25 (3) 467-475;

  5. Mitchell, M A

    1. Physical properties and lipid composition of brain membranes from ethanol tolerant-dependent mice.
      R A Harris, D M Baxter, M A Mitchell and R J Hitzemann
      Molecular Pharmacology May 1984, 25 (3) 401-409;

  6. Momparler, L F

    1. Kinetic interaction of 5-AZA-2'-deoxycytidine-5'-monophosphate and its 5'-triphosphate with deoxycytidylate deaminase.
      R L Momparler, M Rossi, J Bouchard, C Vaccaro, L F Momparler and S Bartolucci
      Molecular Pharmacology May 1984, 25 (3) 436-440;

  7. Momparler, R L

    1. Kinetic interaction of 5-AZA-2'-deoxycytidine-5'-monophosphate and its 5'-triphosphate with deoxycytidylate deaminase.
      R L Momparler, M Rossi, J Bouchard, C Vaccaro, L F Momparler and S Bartolucci
      Molecular Pharmacology May 1984, 25 (3) 436-440;

  8. Murphy, D L

    1. Interactions of phencyclidine with crayfish muscle membranes. Sensitivity to calcium channel antagonists and other drugs.
      E E El-Fakahany, A T Eldefrawi, D L Murphy, L G Aguayo, D J Triggle, E X Albuquerque and M E Eldefrawi
      Molecular Pharmacology May 1984, 25 (3) 369-378;

O

  1. Ohizumi, Y

    1. Mechanism of palytoxin-induced [3H]norepinephrine release from a rat pheochromocytoma cell line.
      M Tatsumi, M Takahashi and Y Ohizumi
      Molecular Pharmacology May 1984, 25 (3) 379-383;

  2. Oswald, R E

    1. Mechanism of phencyclidine binding to the acetylcholine receptor from Torpedo electroplaque.
      R E Oswald, M J Bamberger and J T McLaughlin
      Molecular Pharmacology May 1984, 25 (3) 360-368;

P

  1. Phillips, A W

    1. Antagonism of feedback inhibition. Stimulation of the phosphorylation of thymidine and 5-iodo-2'-deoxyuridine by 5-iodo-5'-amino-2',5'-dideoxyuridine.
      P H Fischer and A W Phillips
      Molecular Pharmacology May 1984, 25 (3) 446-451;

  2. Prusoff, W H

    1. Molecular basis of the antineoplastic activity of 3'-amino-3'-deoxythymidine.
      M S Chen, K L Woods and W H Prusoff
      Molecular Pharmacology May 1984, 25 (3) 441-445;

  3. Pullman, B

    1. A theoretical study of the nonintercalative binding of berenil and stilbamidine to double-stranded (dA-dT)n oligomers.
      N Gresh and B Pullman
      Molecular Pharmacology May 1984, 25 (3) 452-458;

R

  1. Rossi, M

    1. Kinetic interaction of 5-AZA-2'-deoxycytidine-5'-monophosphate and its 5'-triphosphate with deoxycytidylate deaminase.
      R L Momparler, M Rossi, J Bouchard, C Vaccaro, L F Momparler and S Bartolucci
      Molecular Pharmacology May 1984, 25 (3) 436-440;

S

  1. Souccar, C

    1. Interactions of gephyrotoxin with the acetylcholine receptor-ionic channel complex. I. Blockade of the ionic channel.
      C Souccar, W A Varanda, J W Daly and E X Albuquerque
      Molecular Pharmacology May 1984, 25 (3) 384-394;
    2. Interactions of gephyrotoxin with the acetylcholine receptor-ionic channel complex. II. Enhancement of desensitization.
      C Souccar, W A Varanda, R S Aronstam, J W Daly and E X Albuquerque
      Molecular Pharmacology May 1984, 25 (3) 395-400;

  2. Spector, S

    1. Structural requirements for the binding of benzodiazepines to their peripheral-type sites.
      J K Wang, T Taniguchi and S Spector
      Molecular Pharmacology May 1984, 25 (3) 349-351;

  3. Starke, D W

    1. Substrate specificity of the monooxygenase activity of hemoglobin.
      D W Starke, K S Blisard and J J Mieyal
      Molecular Pharmacology May 1984, 25 (3) 467-475;

T

  1. Takahashi, M

    1. Mechanism of palytoxin-induced [3H]norepinephrine release from a rat pheochromocytoma cell line.
      M Tatsumi, M Takahashi and Y Ohizumi
      Molecular Pharmacology May 1984, 25 (3) 379-383;

  2. Taniguchi, T

    1. Structural requirements for the binding of benzodiazepines to their peripheral-type sites.
      J K Wang, T Taniguchi and S Spector
      Molecular Pharmacology May 1984, 25 (3) 349-351;

  3. Tatsumi, M

    1. Mechanism of palytoxin-induced [3H]norepinephrine release from a rat pheochromocytoma cell line.
      M Tatsumi, M Takahashi and Y Ohizumi
      Molecular Pharmacology May 1984, 25 (3) 379-383;

  4. Thurman, R G

    1. Glucuronidation of 7-hydroxycoumarin in periportal and pericentral regions of the liver lobule.
      J G Conway, F C Kauffman, T Tsukada and R G Thurman
      Molecular Pharmacology May 1984, 25 (3) 487-493;

  5. Triggle, D J

    1. Interactions of phencyclidine with crayfish muscle membranes. Sensitivity to calcium channel antagonists and other drugs.
      E E El-Fakahany, A T Eldefrawi, D L Murphy, L G Aguayo, D J Triggle, E X Albuquerque and M E Eldefrawi
      Molecular Pharmacology May 1984, 25 (3) 369-378;

  6. Tsukada, T

    1. Glucuronidation of 7-hydroxycoumarin in periportal and pericentral regions of the liver lobule.
      J G Conway, F C Kauffman, T Tsukada and R G Thurman
      Molecular Pharmacology May 1984, 25 (3) 487-493;

V

  1. Vaccaro, C

    1. Kinetic interaction of 5-AZA-2'-deoxycytidine-5'-monophosphate and its 5'-triphosphate with deoxycytidylate deaminase.
      R L Momparler, M Rossi, J Bouchard, C Vaccaro, L F Momparler and S Bartolucci
      Molecular Pharmacology May 1984, 25 (3) 436-440;

  2. Varanda, W A

    1. Interactions of gephyrotoxin with the acetylcholine receptor-ionic channel complex. I. Blockade of the ionic channel.
      C Souccar, W A Varanda, J W Daly and E X Albuquerque
      Molecular Pharmacology May 1984, 25 (3) 384-394;
    2. Interactions of gephyrotoxin with the acetylcholine receptor-ionic channel complex. II. Enhancement of desensitization.
      C Souccar, W A Varanda, R S Aronstam, J W Daly and E X Albuquerque
      Molecular Pharmacology May 1984, 25 (3) 395-400;

  3. Vilpo, J A

    1. 5-Methyl-2'-deoxycytidine. Metabolism and effects on cell lethality studied with human leukemic cells in vitro.
      A Jekunen and J A Vilpo
      Molecular Pharmacology May 1984, 25 (3) 431-435;

W

  1. Wang, J K

    1. Structural requirements for the binding of benzodiazepines to their peripheral-type sites.
      J K Wang, T Taniguchi and S Spector
      Molecular Pharmacology May 1984, 25 (3) 349-351;

  2. Wasvary, J

    1. Human placenta aldose reductase. Forms sensitive and insensitive to inhibition by alrestatin.
      M E Maragoudakis, J Wasvary, H Hankin and P Gargiulo
      Molecular Pharmacology May 1984, 25 (3) 425-430;

  3. Woods, K L

    1. Molecular basis of the antineoplastic activity of 3'-amino-3'-deoxythymidine.
      M S Chen, K L Woods and W H Prusoff
      Molecular Pharmacology May 1984, 25 (3) 441-445;
Back to top

In this issue

Advertisement